Get started
Author

Julia V. Milne

Observed names: Julia Milne, Julia V Milne, Milne, Julia Valerie
ORCID: 0000-0002-8503-9304
Observed ORCID: 0000-0002-8503-9304
OpenAlex ID: A5044778155
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction
2022 · Kenji M. Fujihara, Bonnie Z. Zhang, et al. · Science Advances · 100
GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma
2020 · Jovana R Gotovac, David SH Liu, et al. · The Journal of Pathology · 23
PDF
Caspase-2 protects against ferroptotic cell death
2024 · Swati Dawar, Mariana C. Benitez, et al. · Cell Death and Disease · 21
PDF
Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus
2021 · Jovana R. Gotovac, Tanjina Kader, et al. · Cellular and Molecular Gastroenterology and Hepatology · 21
PDF
Modelling esophageal adenocarcinoma and Barrett’s esophagus with patient-derived organoids
2024 · Julia V. Milne, Ebtihal H. Mustafa, et al. · Frontiers in Molecular Biosciences · 10
PDF
Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer
2022 · Carlos S. Cabalag, Owen W. J. Prall, et al. · Annals of Surgical Oncology · 10
PDF
Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation
2021 · Julia V. Milne, Bonnie Z. Zhang, et al. · Scientific Reports · 6
PDF
Translational reprogramming drives chromosomal instability during tumorigenesis
2026 · Nicholas Clemons, Julia Milne, et al. · Research Square
PDF
Mapping Functional Tumor Suppressor Networks in Esophageal Adenocarcinoma Using In Vivo CRISPR Screening and Perturb-sequencing
2026 · Ebtihal H Mustafa, Katherine Papastratos, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract 601: Translational reprogramming disrupts mitosis to drive SMAD4-deficient esophageal adenocarcinoma.
2026 · Julia V. Milne, Ka Meng Wu, et al. · Cancer Research
SMAD4 loss drives chromosomal instability during tumourigenesis via translational reprogramming
2026 · Julia V Milne, KaMeng Wu, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract 4065: Unveiling drivers of esophageal adenocarcinoma with CRISPR pooled screen and single-cell RNA-sequencing
2025 · Ebtihal H. Mustafa, Julia Milne, et al. · Cancer Research
Abstract A006: Delineating functional drivers of esophageal adenocarcinoma to identify synthetic lethal interactions
2024 · Julia V Milne, Ebtihal Mustafa, et al. · Molecular Cancer Therapeutics
Abstract PR007: Delineating functional drivers of esophageal adenocarcinoma to identify synthetic lethal interactions
2024 · Julia V. Milne, Ebtihal Mustafa, et al. · Molecular Cancer Therapeutics
Abstract 5578: Multi-omics approach reveals a SMAD4-deficiency signature, translational reprogramming and synthetic lethality in esophageal adenocarcinom
2024 · Julia V. Milne, Kenji Fujihara, et al. · Cancer Research
Abstract A176: Loss of SMAD4 unleashes mTOR and increases dependency on cap-dependent translation in esophageal tumorigenesis
2023 · Julia V Milne, Ebtihal Mustafa, et al. · Molecular Cancer Therapeutics
ASO Visual Abstract: Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer
2022 · Carlos S. Cabalag, Owen W. J. Prall, et al. · Annals of Surgical Oncology
Investigating mechanisms of tumourigenesis and novel therapeutic strategies in oesophageal adenocarcinoma
2022 · Milne, Julia Valerie · Minerva Access (University of Melbourne)
814 Smad4 as a Potential Gatekeeper for Genomic Instability and Mtor-mediated Tumorigenesis in Esophageal Adenocarcinoma
2021 · Julia Milne, Jovana Gotovac, et al. · Diseases of the Esophagus
Abstract 2671: SMAD4 as a potential gatekeeper for genomic instability and mTOR-mediated tumorigenesis in esophageal adenocarcinoma
2021 · Julia V. Milne, Jovana R. Gotovac, et al. · Cancer Research
Works count: 20
Citation count: 191
H-index: 6
I10-index: 6
Year
Topic
Type